Skip to content

Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer

Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06870903
Acronym
ENDONOTE
Enrollment
52
Registered
2025-03-11
Start date
2025-03-15
Completion date
2026-03-01
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer, Lymphadenectomy, Minimally Invasive Surgical Procedures, Natural Orifice Transluminal Endoscopic Surgery, Sentinel Lymph Node Biopsy

Keywords

endometrial cancer, V-NOTES, lymphadenectomy, sentinel lymph node, transperitoneal, extraperitoneal

Brief summary

The aim of this study is to compare two types of lymphadenectomy (transperitoneal vs. paracervical) during the lymphadenectomy phase of endometrial cancer staging surgery performed using V-NOTES, a new and advanced technique. This study seeks to optimize the V-NOTES technique for endometrial cancer staging. This randomized, prospective, controlled study will include patients diagnosed with endometrial cancer via histology, following physical examination and imaging, and who are electively scheduled for the V-NOTES endometrial cancer staging procedure. Patients will be randomized into two groups: the transvaginal paracervical lymphadenectomy group and the transperitoneal lymphadenectomy group. The parameters related with surgical and functional outcomes will be compared in both groups.

Detailed description

Surgical staging is often the primary management strategy for endometrial cancer. Sentinel lymph node (SLN) procedures are considered an alternative standard of care in the treatment of significant uterus-confined malignancy. Both accurately estimate nodal status and reduce the surgical morbidity associated with complete lymphadenectomy. Laparoscopic surgery for endometrial cancer has been associated with equal or better quality of life, less blood loss and similar cancer-related outcomes. A new innovation, natural orifice transluminal endoscopic surgery (NOTES), has been developed to further reduce morbidity and scarring associated with laparoscopic surgery. NOTES utilizes the natural orifices of the human body for access to the peritoneal cavity when performing endoscopic surgery. However, there is no standardization in vNOTES SLN mapping and lymph tracers are diverse. Many procedures and tracers have been reported, such as intra- or retroperitoneal surgery, a range of vaginal surgeries, SLN exposure method, and indocyanine green or methylene blue injection, and they lack comparative studies. This study will evaluate feasibility and surgical outcomes by comparing transvaginal paracervical and transperitoneal mapping in vNOTES hysterectomy with SLN procedure in endometrial cancer. The study is an observational study with a prospective design. It will be implemented in a single institution, specifically Diyarbakır Gazi Yaşargil Training and Research Hospital, which functions as a tertiary cancer treatment facility. Between March 2025 and December 2025, patients with newly diagnosed clinical early stage (FIGO 2023 stages 1 and 2) endometrial cancer who will be treated with laparoscopic surgical staging with SLN mapping. According to inclusion and exclusion criteria, the patients will be randomized into two groups: the transvaginal paracervical lymphadenectomy group and the transperitoneal lymphadenectomy group. Surgical Procedure of transvaginal paracervical sentinel lymphadenectomy group: All patients(26) will receive V-NOTES with transvaginal paracervical sentinel lymph node (SLN) mapping followed by V-NOTES hysterectomy and bilateral salpingo-oophorectomy (BSO). Transperitoneal sentinel lenfadenectomy group's Surgical Procedure: All patients (26) will receive vNOTES hysterectomy with bilateral salpingo-oophorectomy (BSO) followed by transperitoneal vNOTES sentinel lymph node (SLN) mapping.

Interventions

PROCEDUREExtraperitoneal(transvaginal paracervical sentinel lymphadenectomy) group lymphadenectomy

The procedure begins with a vaginal incision in the lateral vaginal fornices (on both sides), which is then extended to allow placement of the V-NOTES apparatus. By identifying an appropriate cleavage plane, the obturator fossa is accessed to excise the obturator lymph nodes. Following this, an anterior colpotomy is performed to access the vesicocervical space, and a posterior colpotomy is made to open the rectouterine pouch. The V-NOTES apparatus is then placed to continue with the hysterectomy and bilateral salpingo-oophorectomy (BSO).

PROCEDURETransperitoneal lymphadenectomy

In this arm, patients will undergo transperitoneal lymphadenectomy with V-NOTES. The procedure begins with anterior and posterior colpotomies, followed by placement of the V-NOTES apparatus. Hysterectomy is performed first, followed by peritoneal dissection and lymph node excision.

Sponsors

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Patient Selection and Data Collection This study will be implemented in a single institution, Diyarbakır Gazi Yaşargil Training and Research Hospital, which functions as a tertiary cancer treatment facility. Between March 2025 and December 2025, patients with newly diagnosed clinical early stage (FIGO 2023 stages 1 and 2) endometrial cancer who will be treated with laparoscopic surgical staging with SLN mapping at our institution will be randomized into groups. The research procedure has been approved by the ethics committee/institutional review board of Diyarbakır Gazi Yaşargil Training and Research Hospital and informed consent signed by the patient will be included in each table reviewed. Eligible participants will be required to give informed consent to participate in the study. Inclusion criteria will include * Participants whose endometrial biopsy resulted in endometrial cancer and whose disease will be detected limited to the uterus using imaging modalities (computed tomography \[CT\], magnetic resonance imaging or Fluorine-18 fluorodeoxyglucose positron emission tomography/CT) * Absence of synchronous malignancies. * No neoadjuvant treatment before surgical intervention.

Exclusion criteria

will include: * Contraindications to using methylene blue dye or contraindications to the vNOTES procedure. * Patients who have had previous malignancy surgery. * Severe, deeply penetrating endometriosis or enlarged uterus that may require forced vaginal extraction * Receiving neodajuvant therapy

Design outcomes

Primary

MeasureTime frameDescription
Duration of lateral colpotomyDuring surgeryat transvaginal retroperitoneal procedure ; before the lymphadenectomy we are making and incision to the lateral of cervix .this time describes the time that to reach the obturator fossa to pick the nodes.
Total bleeding volumeDuring surgeryMeasured by the suction bottle's volume and number of surgical gauzse used during surgery
Difference between pre- and postoperative hemoglobin valuesPostoperative 1st dayHemoglobin level (g/dL)
Surgical complicationsDuring hospital stayClavien dindo scale of surgical complications
Location o SLNDuring surgeryThe area that sentinel lymph node detected internal iliac, external iliac ,bifurcation or obturator fossa
Preoperative and postoperative hematocrit valuesDuring hospital stayHematocrit level (%)
Tumor's patological featuresPostoperative second weekHistophatology, grade, lymphovascular invasion, tumor diameter(cm), myometrial invasion, stage, total positive lymph node count
Management of complicationsthrough study completionintraoperative and postoperative complication's management
Duration of hysterectomyDuring surgeryminutes
Sentinel lymphnode's side and numberPostoperative second weeknumber
Total operation durationDuring surgeryThe total duration of the operation in minutes
Duration of right and left lymphadenectomyDuring surgeryThe duration of lymphadenectomies in minutes
Number of lymph nodes excisedPostoperative second weekLymph node count in the pathology report
number of positive lymph nodesPostoperative second weekSentinel positive lymph nodes in the pathology report
Hospitalization durationDuring hospital stayNumber of days patients stayed at the hospital postoperatively

Secondary

MeasureTime frameDescription
Sexual functionat postoperative 3rd and 6th monthassessed by Female Sexual Function Index, higher scores indicate greater satisfaction
Timing of passing gasDuring hospital stayBowel function
Demographic featuresPostoperative second weekAge, gravidity, parity, previous vaginal delivery, body-mass index
Previous abdominal surgeryPreoperative dayMedical history
Initiation of mobilizationDuring hospital stayAfter operation the time (hour) that paient is avaliable to mobilize out from the bed
6th hour and 24th hour VAS scorepostoperatively 6th and 24th hours scoreThe visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain.
Postoperative pain3rd and 6th month after operationvisual analogue scale, higher scores indicate worse pain

Countries

Turkey (Türkiye)

Contacts

Primary ContactKevser Arkan, MD
kevser.toprak1989@gmail.com+905536476838

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026